SENS vs TLSI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
SENS exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 1/9, indicating critical failures in profitability and operational efficiency. While the company shows impressive top-line revenue growth of 71.80% and maintains a strong liquidity position (Current Ratio 4.83), these are offset by a devastating profit margin of -196.03% and a consistent track record of missing earnings estimates. The stock is in a long-term bearish trend with a 5-year decline of 81.7%, suggesting that the market is discounting the growth in favor of the unsustainable burn rate.
TLSI exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -6.79, indicating negative shareholders' equity. While the company shows strong top-line revenue growth of 59.80% and high gross margins, these are offset by a devastating profit margin of -86.88% and consistent earnings misses. The stark disconnect between the 'Strong Buy' analyst consensus and the bearish insider selling by the CEO and officers suggests a high-risk speculative profile. Overall, the deterministic health indicators signal a high probability of further capital erosion or dilution.
Compare Another Pair
Related Comparisons
SENS vs TLSI: Head-to-Head Comparison
This page compares Senseonics Holdings, Inc. (SENS) and TriSalus Life Sciences, Inc. (TLSI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.